Bolt Biotherapeutics's total assets for Q4 2024 were $99.63M, a decrease of -8.87% from the previous quarter. BOLT total liabilities were $42.43M for the fiscal quarter, a 13.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.